Image

Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody

Join our study on preventing C. Diff infections with AZD5148.

Recruiting
18 years and older
All
Phase 2
**Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody**

This study tests a medicine called AZD5148 to stop Clostridioides difficile (C. difficile) infections from coming back. C. difficile is a germ that can cause bad stomach problems like diarrhea. The study is for people 18 years and older.

About the study: 230 people will join and get either AZD5148 or a placebo (a fake treatment) by a shot in the muscle or a push into a vein. The study will have up to 9 visits, including 2 site visits for eligibility and dose administration, and up to 7 planned visits. Phone calls and an electronic diary will be part of the follow-up.

Key Points:

  • The study involves up to 9 visits and regular follow-ups.
  • Participants will receive either the medicine or a placebo.
  • No diarrhea is needed on the day of treatment.

To join, you must not have certain other bowel diseases or have had specific surgeries. If you have had a fecal transplant or certain other treatments recently, you cannot join. You must weigh at least 40 kg (about 88 pounds).

Study details
    Clostridioides Difficile Infection

NCT07285213

AstraZeneca

11 April 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race
Ethnicity
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.